Based on these numbers we discuss the psychometric properties of the HF, especially its potential to
detect patients in need for additional treatment.
Not exact matches
Whereas it may require an 18 - month trial
in 1,000 to 2,000
patients to determine if a drug is effective for Alzheimer's, «you probably only
need six to 12 months and 200 to 300
patients for the same sort of power to
detect a drug's disease - modifying effect
in PSP,» says U.C. San Francisco's Boxer.
Besides, the developed immunosensor is found highly selective to NS1 biomarker and it is able to
detect the NS1 antigen directly
in actual serum specimens collected from
patients who has been infected with Dengue virus, without sample preparation steps
needed.
A tool intended to
detect signs of autism
in high - risk infants can be used to help identify and treat
patients with tuberous sclerosis complex (TSC), a genetic disorder, who most
need early intervention.
Researchers say the test — which
detects levels of specific molecules
in blood — will help doctors identify which
patients arriving
in hospital
need more intense treatment.
«Screening strategies that include assays with the ability to
detect TRK fusions will be
needed in order to identify
patients who may benefit from larotrectinib.»
In order to
detect such an effect size, power calculations showed that a trial would
need to include 548
patients.